| Dr Julie Anne Wolf, OD | |
|
Vision Center, Nisky Shopping Center, St Thomas, VI 00803 | |
| (340) 776-2020 | |
| (340) 776-2021 |
| Full Name | Dr Julie Anne Wolf |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 29 Years |
| Location | Vision Center, St Thomas, Virgin Island |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144309956 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 2918 (Florida) | Secondary |
| 152W00000X | Optometrist | OPT00001493 (Georgia) | Secondary |
| 152W00000X | Optometrist | 065 (Virgin Island) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St. Croix Vision Center Inc | 9931349214 | 6 |
News Archive
November is Chronic Obstructive Pulmonary Disease (COPD) Awareness Month. COPD, also known as emphysema, is the third leading cause of death in the United States, only behind heart disease and cancer. Right now, the only studied interventions that prolong life for patients with severe COPD are supplemental oxygen in people with low oxygen levels and lung volume reduction surgery (LVRS) in appropriately selected individuals.
Georg-August-University Gottingen, University of Regensburg and MRC Technology (MRCT) have signed exclusive license agreements through MBM ScienceBridge GmbH and in agreement with Bayerische Patentallianz GmbH, for the development of a novel therapy of inflammatory and immune diseases based on the depletion of inflammatory monocytes. The first targets will be rheumatoid arthritis (RA) and multiple sclerosis (MS).
Scientists at James Cook University have taken the lead in developing a new vaccine against a highly infectious cattleyard disease caused by a bacteria which has the potential to be developed as a bioterrorist weapon.
Elsevier, a world-leading publisher of scientific, technical and medical information products and services, today announced the launch of SciVerse, an innovative platform that integrates the company's key products and encourages the scientific community to collaborate on the development of customized search and discovery applications. Elsevier has committed to releasing the APIs for all of the content on SciVerse and will offer application development support tools on the site.
Apitope, the European drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today announced completion of recruitment into its second Phase I clinical trial of ATX-MS-1467 in patients with multiple sclerosis (MS).
› Verified 1 days ago
| Provider Name | St. Croix Vision Center Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1669698387 PECOS PAC ID: 9931349214 Enrollment ID: O20130710000144 |
News Archive
November is Chronic Obstructive Pulmonary Disease (COPD) Awareness Month. COPD, also known as emphysema, is the third leading cause of death in the United States, only behind heart disease and cancer. Right now, the only studied interventions that prolong life for patients with severe COPD are supplemental oxygen in people with low oxygen levels and lung volume reduction surgery (LVRS) in appropriately selected individuals.
Georg-August-University Gottingen, University of Regensburg and MRC Technology (MRCT) have signed exclusive license agreements through MBM ScienceBridge GmbH and in agreement with Bayerische Patentallianz GmbH, for the development of a novel therapy of inflammatory and immune diseases based on the depletion of inflammatory monocytes. The first targets will be rheumatoid arthritis (RA) and multiple sclerosis (MS).
Scientists at James Cook University have taken the lead in developing a new vaccine against a highly infectious cattleyard disease caused by a bacteria which has the potential to be developed as a bioterrorist weapon.
Elsevier, a world-leading publisher of scientific, technical and medical information products and services, today announced the launch of SciVerse, an innovative platform that integrates the company's key products and encourages the scientific community to collaborate on the development of customized search and discovery applications. Elsevier has committed to releasing the APIs for all of the content on SciVerse and will offer application development support tools on the site.
Apitope, the European drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today announced completion of recruitment into its second Phase I clinical trial of ATX-MS-1467 in patients with multiple sclerosis (MS).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Julie Anne Wolf, OD Po Box 305251, St Thomas, VI 00803-5251 Ph: (770) 596-0823 | Dr Julie Anne Wolf, OD Vision Center, Nisky Shopping Center, St Thomas, VI 00803 Ph: (340) 776-2020 |
News Archive
November is Chronic Obstructive Pulmonary Disease (COPD) Awareness Month. COPD, also known as emphysema, is the third leading cause of death in the United States, only behind heart disease and cancer. Right now, the only studied interventions that prolong life for patients with severe COPD are supplemental oxygen in people with low oxygen levels and lung volume reduction surgery (LVRS) in appropriately selected individuals.
Georg-August-University Gottingen, University of Regensburg and MRC Technology (MRCT) have signed exclusive license agreements through MBM ScienceBridge GmbH and in agreement with Bayerische Patentallianz GmbH, for the development of a novel therapy of inflammatory and immune diseases based on the depletion of inflammatory monocytes. The first targets will be rheumatoid arthritis (RA) and multiple sclerosis (MS).
Scientists at James Cook University have taken the lead in developing a new vaccine against a highly infectious cattleyard disease caused by a bacteria which has the potential to be developed as a bioterrorist weapon.
Elsevier, a world-leading publisher of scientific, technical and medical information products and services, today announced the launch of SciVerse, an innovative platform that integrates the company's key products and encourages the scientific community to collaborate on the development of customized search and discovery applications. Elsevier has committed to releasing the APIs for all of the content on SciVerse and will offer application development support tools on the site.
Apitope, the European drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today announced completion of recruitment into its second Phase I clinical trial of ATX-MS-1467 in patients with multiple sclerosis (MS).
› Verified 1 days ago
Dr. Heena A Udhwani, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 9200 Vitraco Park Mall, Ste 12, St Thomas, VI 00802 Phone: 340-715-3937 Fax: 340-715-3934 | |
Vision Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 8000 Nisky Center, Suite 19, St Thomas, VI 00802 Phone: 340-776-2020 | |
Dr. Monica Bidot Lopez, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 9000 Lockhart Gdn Ctr Ste 202, St Thomas, VI 00802 Phone: 340-774-8500 Fax: 340-774-3704 | |
Dr. Craig Friedenberg, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6500 Red Hook Plz Ste 225, St Thomas, VI 00802 Phone: 340-779-2019 Fax: 340-779-2020 | |
Dr. Richworth Philip, O.D Optometrist Medicare: Not Enrolled in Medicare Practice Location: 9400 Wheatley Center#1, Carib Eyecare, St Thomas, VI 00802 Phone: 340-774-6677 | |
Vision Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4605 Tutu Park Mall, St Thomas, VI 00802 Phone: 340-774-2020 |